Navigation Links
Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
Date:12/20/2007

ues, and represented the United Kingdom on the Biologics Working Party of the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMEA). He also worked as Senior Director, Head of European Regulatory Affairs for Shire Human Genetic Therapies, Ltd. Prior to that, Dr. Forsey worked for Pharmacia, Amgen, the National Institute for Biological Standards and Control and the University of London. In all, he brings more than 30 years of pharmaceutical, governmental and research experience to his role with Kendle.

Dr. Forsey earned a doctorate in microbiology from the University of London and a Bachelor of Science in microbiology from the University of Surrey, England. A widely-published author, he is a registered member of The Organisation for Professionals in Regulatory Affairs (TOPRA) and the Drug Information Association (DIA).

Dr. Forsey is the latest member of an international team of pharmaceutical, clinical and non-clinical biotechnology experts Kendle has assembled with backgrounds encompassing regulatory agencies on three continents, as well as experience working for a variety of pharmaceutical companies and academic and research institutions.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations and is the fourth-largest provider of Phase II-IV clinical development services worldwide. We deliver innovative and robust clinical development solutions - from first-in-human studies through market launch and surveillance - to help the world's biopharmaceutical companies maximize product life cycles and grow market share.

Our global clinical development business is focused on five regions - North America, Europe, Asia/P
'/>"/>

SOURCE Kendle International Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22
2. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
3. Kendle to Present at Thomas Weisel Partners Healthcare Conference 2007
4. Kendle to Present at Bear Stearns 20th Annual Healthcare Conference
5. Kendle to Present at the UBS Global Life Sciences Conference
6. Kendle to Present at the Natixis Bleichroeder Hidden Gems Conference
7. Kendle Invites You to Attend Its Third Quarter 2007 Earnings Conference Call and Webcast
8. Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
9. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
10. Codexis Appoints Singapore Laboratories Managing Director
11. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... -- Last week, Representatives Gus Bilirakis (R-FL) ... bold bipartisan step on behalf of patients with ... co-sponsors of the legislation include Representatives McCaul (R-TX) ... makers and innovators to "repurpose" major market drugs ... opens the door to the development of hundreds ...
(Date:11/24/2014)... Continental Clinical Solutions, LLC (Continental) focuses ... at its mid-Atlantic late-phase research facility, located in ... the idea of closing patient disparities in mind. ... advances," said Continental's CEO, Saleh Stevens . ... cell line of Henrietta Lacks, dubious ethical practices ...
(Date:11/23/2014)... 23, 2014 Apiscent Labs, a ... fine chemical ingredients to the global pharmaceutical and ... its new website, Apiscent.com. , The Apiscent.com homepage ... clean design, easy navigation, rotating images and content ... stand out. , The company’s work ...
(Date:11/22/2014)... RURO, Inc., a leading LIMS, RFID ... version 5.1.4. , RURO’s deployment teams have been ... in RURO’s 8 year history. Many deployments have ... version 5.1.4 is the perfect example – the ... , Limfinity® 5.1.4 release highlights – more than ...
Breaking Biology Technology:OPEN Act Introduced to Repurpose Drugs for Rare Diseases 2At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 2At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 3RURO Announces Limfinity® version 5.1.4 2
... A recent study* at the National Institute of ... optimal characteristics for a new type of computer ... collaboration with researchers from George Mason University (GMU), ... illuminating the path to creating portable computers and ...
... 2011 Rules-Based Medicine (RBM), a global leader ... Neurotech, has achieved a significant milestone in a ... from a Roche clinical trial, the RBM DiscoveryMAP® ... biomarker pattern was identified that has utility in ...
... Board of Directors is pleased to announce the appointment of ... succeeds Gerard Barba, who will remain the Chairman of the ... management team have sought to add an executive such as ... life science industry as well as a strong background in ...
Cached Biology Technology:NIST 'nanowire' measurements could improve computer memory 2Rules-Based Medicine Reaches a Significant Milestone in Companion Diagnostic Program With Roche 2Wes Wheeler Appointed as CEO by Marken's Board of Directors 2
(Date:11/18/2014)... Nov. 17, 2014   News ... collaborate to develop The Partners Data Lake, an ... Partners Data Lake will allow researcher and clinicians ... treatment and the lives of patients , ... clinical activities across the Partners system, breaking down ...
(Date:11/15/2014)... 2014  While we may still be a few years ... "Star Trek" to gain instant access to all that ailed ... smartphones and tablets for monitoring and measuring our health are ... may seem a tad Orwellian to some, but a new ... these technological opportunities into their healthcare regime. These ...
(Date:11/10/2014)... shelves in early 2010, and people have used them ... be tossed into a washing machine without ever having ... though, has come with risks for young children. , ... found that from 2012 through 2013, U.S. poison control ... years of age swallowing, inhaling, or otherwise being exposed ...
Breaking Biology News(10 mins):Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4Study finds laundry detergent pods, serious poisoning risk for children 2
... has developed a robust, efficient method of using hydrogen as a ... can easily be converted to electricity in a fuel cell and ... because it is a gas, it can only be stored in ... a tank full of hydrogen, "if you got into a wreck, ...
... are excited about the prospect of gaining more efficient ... or switchgrass rather than corn. They have ... key factor of agriculture has been overlooked: water. ... bioenergy crops, dependence on water gets ignored, and water ...
... for Molecular Pathology (AMP) submitted comments to the ... guidance document titled, "Commercially Distributed In Vitro Diagnostic ... Use Only: Frequently Asked Questions." AMP is very ... of patient care by severely reducing the availability ...
Cached Biology News:Testing the water for bioenergy crops 2FDA draft guidance document may limit patient access to tests 2
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
Formula variant: With macro- and micronutrients. Physical Form: powder Suitab tst: plant cell culture tested...
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
Four siRNAs targeting your gene of interest, providing gene silencing with 100% satisfaction guaranteed High knockdown potency , High specificity for minimal off-target effects , Flexible siR...
Biology Products: